Measuring non-vitamin K antagonist oral anticoagulant levels: When is it appropriate and which methods should be used?
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Measuring non-vitamin K antagonist oral anticoagulant levels: When is it appropriate and which methods should be used?
Authors
Keywords
-
Journal
International Journal of Stroke
Volume 11, Issue 7, Pages 748-758
Publisher
SAGE Publications
Online
2016-07-14
DOI
10.1177/1747493016659671
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Measurement of dabigatran, rivaroxaban and apixaban in samples of plasma, serum and urine, under real life conditions. An international study
- (2016) Job Harenberg et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Safety of Endovascular Thrombectomy in Patients Receiving Non–Vitamin K Antagonist Oral Anticoagulants
- (2016) Jan C. Purrucker et al. STROKE
- Recanalization Therapies in Acute Ischemic Stroke PatientsCLINICAL PERSPECTIVES
- (2015) David J. Seiffge et al. CIRCULATION
- Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
- (2015) Hein Heidbuchel et al. EUROPACE
- Safety of intra-arterial treatment in acute ischaemic stroke patients on oral anticoagulants. A cohort study and systematic review
- (2015) A. D. Rozeman et al. EUROPEAN JOURNAL OF NEUROLOGY
- Site-Level Variation in and Practices Associated With Dabigatran Adherence
- (2015) Supriya Shore et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Laboratory measurement of the anticoagulant activity of edoxaban: a systematic review
- (2015) Adam Cuker et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial
- (2015) Christian T Ruff et al. LANCET
- Targeted Anti-Anticoagulants
- (2015) Kenneth A. Bauer NEW ENGLAND JOURNAL OF MEDICINE
- Idarucizumab for Dabigatran Reversal
- (2015) Charles V. Pollack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Point-of-Care Testing of Coagulation in Patients Treated With Non–Vitamin K Antagonist Oral Anticoagulants
- (2015) Matthias Ebner et al. STROKE
- A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran
- (2015) Viktoria Moschetti et al. THROMBOSIS AND HAEMOSTASIS
- Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure
- (2015) Jeff S. Healey et al. THROMBOSIS AND HAEMOSTASIS
- Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation
- (2015) Franziska Ebertz et al. THROMBOSIS AND HAEMOSTASIS
- Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry
- (2014) J. Beyer-Westendorf et al. BLOOD
- Coagulation assays and plasma fibrinogen concentrations in real-world patients with atrial fibrillation treated with dabigatran
- (2014) Paul K. L. Chin et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry
- (2014) J. Beyer-Westendorf et al. EUROPEAN HEART JOURNAL
- Prevalence of renal dysfunction in ischaemic stroke and transient ischaemic attack patients with or without atrial fibrillation
- (2014) M. Laible et al. EUROPEAN JOURNAL OF NEUROLOGY
- Laboratory Monitoring of the Non–Vitamin K Oral Anticoagulants∗
- (2014) Andrew D. Blann et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dabigatran: how the drug company withheld important analyses
- (2014) D. Cohen BMJ-British Medical Journal
- Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: Proposals of the Working Group on Perioperative Haemostasis (GIHP) – March 2013
- (2013) Gilles Pernod et al. Archives of Cardiovascular Diseases
- The laboratory and the direct oral anticoagulants
- (2013) A. Tripodi BLOOD
- Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis
- (2013) Sam Schulman et al. CIRCULATION
- Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban
- (2013) Wolfgang Mueck et al. CLINICAL PHARMACOKINETICS
- Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban
- (2013) T. Steiner et al. Clinical Research in Cardiology
- Evaluation of coagulation assays versus LC-MS/MS for determinations of dabigatran concentrations in plasma
- (2013) Jovan P. Antovic et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Perioperative management of patients who are receiving a novel oral anticoagulant
- (2013) Aaron Liew et al. Internal and Emergency Medicine
- The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients
- (2013) Paul A. Reilly et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Apixaban for the Treatment of Acute Venous Thromboembolism
- (2013) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatran
- (2012) Joachim Stangier et al. BLOOD COAGULATION & FIBRINOLYSIS
- Oral Anticoagulant Therapy
- (2012) Walter Ageno et al. CHEST
- Perioperative Management of Antithrombotic Therapy
- (2012) James D. Douketis et al. CHEST
- Risks of Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Receiving Warfarin and Treated With Intravenous Tissue Plasminogen Activator
- (2012) Ying Xian et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban—an oral, direct and selective factor Xa inhibitor
- (2011) Richard C. Becker et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls
- (2011) Genevieve Contant et al. THROMBOSIS AND HAEMOSTASIS
- Oral Rivaroxaban for Symptomatic Venous Thromboembolism
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation
- (2010) Stuart Connolly et al. THROMBOSIS AND HAEMOSTASIS
- An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasma
- (2010) Jean Amiral et al. THROMBOSIS AND HAEMOSTASIS
- Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
- (2010) Joachim Stangier et al. THROMBOSIS AND HAEMOSTASIS
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
- (2009) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Point-of-Care International Normalized Ratio Testing Accelerates Thrombolysis in Patients With Acute Ischemic Stroke Using Oral Anticoagulants
- (2009) Timolaos Rizos et al. STROKE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More